Industry News (Joint Ventures)

Agreement Signed for Tuberculosis Tests with Remel LP

Published in AIDS Weekly, November 20th, 1995

DynaGen Inc., Cambridge, Massachusetts, announced that it has signed a manufacturing and distribution agreement with Remel LP, Lenexa, Kansas, that markets and distributes microbiology products worldwide.

Under this agreement, Remel has the exclusive rights to manufacture and sell DynaGen's MycoAKT latex agglutination products in the United States and semi-exclusive rights for the rest of the world. The MycoAKT tests are used for the identification of mycobacterial species isolated in culture. DynaGen obtained U.S. Food and Drug Administration (FDA) marketing clearance for its three MycoAKT tests earlier in 1995. Financial terms were not disclosed.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1995-11-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry